The effect of amelogenins (Xelma™) on hard-to-heal venous leg ulcers

Wound Repair and Regeneration

Volumn 14, Issue 3, 2006, Pages 240-246

  Vowden, Peter ^a   Romanelli, Marco ^b   Peter, Ralf ^c   Boström, Åsa ^d   Josefsson, Anna ^e   Stege, Helger ^f  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF PISA   (Italy)

^c Hospital and Clinic for Vascular Surgery and Dermatology   (Germany)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID PROPYLENE GLYCOL ESTER; AMELOGENIN; XELMA;

ADULT; AGING; ARTICLE; BANDAGING TECHNIQUE; CLINICAL TRIAL; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; GRANULATION TISSUE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; WOUND DRESSING; WOUND HEALING;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMELOGENIN; BANDAGES; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; VARICOSE ULCER; WOUND HEALING;

EID: 33745560853     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00117.x     Document Type: Article

References (34)

1. Douglas WS, Simpson NB. Guidelines for the management of chronic venous leg ulceration. Report of a multidisciplinary workshop. British Association of Dermatologists and the research unit of the Royal College of Physicians. Br J Dermatol 1995; 132: 446-52.
2. Nelzen O, Bergqvist D, Lindhagen A. Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study. Eur J Vasc Endovasc Surg 1997; 13: 500-8.
3. Brem H, Kirsner RS, Falanga V. Protocol for the successful treatment of venous ulcers. Am J Surg 2004; 188 (1A Suppl.): 1-8.
4. Evans CJ, Lee AJ, Ruckley CV, Fowkes FRG. How common is venous disease in the general population? In: Ruckley CV, Fowkes FGR, Bradbury AW, editors. Venous disease: Epidemiology, management, and delivery of care. London: Springer-Verlag, 1999: 3-14.
5. Nicolaides AN. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation 2000; 102: E126-63.
6. Franks P. Quality of life for leg ulcer patients. In: Ruckley CV, Fowkes FGR, Bradbury AW, editors. Venous Disease: Epidemiology, management and delivery of care. London: Springer, 1999: 42-50.
7. Stacey MC, Falanga V, Marston W, Moffatt C, Phillips T, Sibbald RG, Varnscheidt W, Lindholm C. The use of compression therapy in the treatment of venous leg ulcers. Eur Wound Management Assoc J 2002; 2: 9-13.
8. Moffatt CJ, Franks PJ, Oldroyd M, Bosanquet N, Brown P, Greenhalgh RM, McCollum CN. Community clinics for leg ulcers and impact on healing. Bri Med J 1992; 305: 1389-92.
9. Vowden KR, Barker A, Vowden P. Leg ulcer management in a nurse-led, hospital-based clinic. J Wound Care 1997; 6: 233-6.
10. Lambourne LA, Moffatt CJ, Jones AC, Dorman MC, Franks PJ. Clinical audit and effective change in leg ulcer services. J Wound Care 1996; 5: 348-51.
11. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Rep Reg 2004; 12: 163-8.
12. Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V. Prognostic indicators in venous ulcers. J Am Acad Dermatol 2000; 43: 627-30.
13. Margolis DJ, Gelfand JM, Hoffstad O, Berlin JA. Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diab Care 2003; 26: 1696-700.
14. Moffatt C, editor. Understanding compression therapy. London: Medical Education Partnership, 2003.
15. Moffatt CJ, Simon DA, Franks PJ, Connolly M, Fielden S, Groarke L, et al. Randomised trial comparing two four-layer bandage systems in the management of chronic leg ulceration. Phlebology 1999; 14: 139-42.
16. Vowden KR, Mason A, Wilkinson D, Vowden P. Comparison of the healing rates and complications of three four-layer bandage regimens. J Wound Care 2000; 9: 269-72.
17. Moffatt CJ, McCullagh L, O'Connor T, Doherty DC, Hourican C, Stevens J, Mole T, Franks PJ. Randomized trial of four-layer and two-layer bandage systems in the management of chronic venous ulceration. Wound Rep Reg 2003; 11: 166-71.
18. Partsch H, Damstra RJ, Tazelaar DJ, Schuller-Petrovic S, Velders AJ, de Rooij MJ, Sang RR, Quinlan D. Multicenter, randomised controlled trial of four-layer bandaging versus short-stretch bandaging in the treatment of venous leg ulcers. Vasa 2001; 30: 108-13.
19. Guzman-Gardearzabal E, Leyva-Bohorquez G, Salas-Colin S, Paz-Janeiro JL, Alvarado-Ruiz R, Garcia-Salazar R. Treatment of chronic ulcers in the lower extremities with topical becaplermin gel.01%: a multicenter open-label study. Adv Ther 2000; 17: 184-9.
20. Omar AA, Mavor AI, Jones AM, Homer-Vanniasinkam S. Treatment of venous leg ulcers with Dermagraft. Eur J Vasc Endovasc Surg 2004; 27: 666-72.
21. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Rep Reg 1999; 7: 201-7.
22. Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treatments in ulcer healing and wound infection. Diab Metab Res Rev 2000; 16 (Suppl 1.): S51-4.
23. Hammarstrom L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997; 24 (Part 2): 669-77.
24. Fincham AG, Moradian-Oldak J, Simmer JP. The structural biology of the developing dental enamel matrix. J Struct Biol 1999; 126: 270-99.
25. Esposito M, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev 2003; CD003875.
26. Wennstrom JL, Lindhe J. Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 2002; 29: 9-14.
27. Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24 (9 Pt 2): 705-14.
28. Heden G, Wennstrom J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999; 26: 855-60.
29. Mirastschijski U, Konrad D, Lundberg E, Petter Lyngstadaas S, Jorgensen LN, Agren MS. Effects of a topical enamel matrix derivative on skin wound healing. Wound Rep Reg 2004; 12: 100-8.
30. Yuan K, Chen CL, Lin MT. Enamel matrix derivative exhibits angiogenic effect in vitro and in a murine model. J Clin Periodontol 2003; 30: 732-8.
31. Schultz GS, Ladwig G, Wysocki A. Extracellular matrix: review of its role in acute and chronic wounds. In: World Wide Wounds (www.worldwidewounds.com): Surgical Materials Testing Laboratory in Association with the Medical Education Partnership; 2005.
32. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Reg 1996; 4: 11-20.
33. Roy F, DeBlois C, Doillon CJ. Extracellular matrix analogs as carriers for growth factors: in vitro fibroblast behavior. J Biomed Mater Res 1993; 27: 389-97.
34. Girotti A, Reguera J, Rodriguez-Cabello JC, Arias FJ, Alonso M, Matestera A. Design and bioproduction of a recombinant multi(bio)functional elastin-like protein polymer containing cell adhesion sequences for tissue engineering purposes. J Mater Sci Mater Med 2004; 15: 479-84.